These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 38274097)

  • 1. Loss of filamentous actin, tight junction protein expression, and paracellular barrier integrity in frataxin-deficient human brain microvascular endothelial cells-implications for blood-brain barrier physiology in Friedreich's ataxia.
    Smith FM; Kosman DJ
    Front Mol Biosci; 2023; 10():1299201. PubMed ID: 38274097
    [No Abstract]   [Full Text] [Related]  

  • 2. Frataxin-deficient human brain microvascular endothelial cells lose polymerized actin and are paracellularly permeable -implications for blood-brain barrier integrity in Friedreich's Ataxia.
    Smith FM; Kosman DJ
    bioRxiv; 2023 Feb; ():. PubMed ID: 36798283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Defects in Friedreich's Ataxia: Convergence of Oxidative Stress and Cytoskeletal Abnormalities.
    Smith FM; Kosman DJ
    Front Mol Biosci; 2020; 7():569293. PubMed ID: 33263002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation between frataxin expression and contractility revealed by in vitro Friedreich's ataxia cardiac tissue models engineered from human pluripotent stem cells.
    Wong AO; Wong G; Shen M; Chow MZ; Tse WW; Gurung B; Mak SY; Lieu DK; Costa KD; Chan CW; Martelli A; Nabhan JF; Li RA
    Stem Cell Res Ther; 2019 Jul; 10(1):203. PubMed ID: 31286988
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial damage and senescence phenotype of cells derived from a novel frataxin G127V point mutation mouse model of Friedreich's ataxia.
    Fil D; Chacko BK; Conley R; Ouyang X; Zhang J; Darley-Usmar VM; Zuberi AR; Lutz CM; Napierala M; Napierala JS
    Dis Model Mech; 2020 Jul; 13(7):. PubMed ID: 32586831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progressive mitochondrial protein lysine acetylation and heart failure in a model of Friedreich's ataxia cardiomyopathy.
    Stram AR; Wagner GR; Fogler BD; Pride PM; Hirschey MD; Payne RM
    PLoS One; 2017; 12(5):e0178354. PubMed ID: 28542596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in the Elucidation of Frataxin Biochemical Function Open Novel Perspectives for the Treatment of Friedreich's Ataxia.
    Monfort B; Want K; Gervason S; D'Autréaux B
    Front Neurosci; 2022; 16():838335. PubMed ID: 35310092
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heart disease in Friedreich's ataxia.
    Hanson E; Sheldon M; Pacheco B; Alkubeysi M; Raizada V
    World J Cardiol; 2019 Jan; 11(1):1-12. PubMed ID: 30705738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranslational regulation of mitochondrial frataxin and identification of compounds that increase frataxin levels in Friedreich's ataxia.
    Hackett PT; Jia X; Li L; Ward DM
    J Biol Chem; 2022 Jun; 298(6):101982. PubMed ID: 35472330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of cell-free levels of iron and copper in patients with Friedreich's ataxia.
    Pathak D; Srivastava AK; Gulati S; Rajeswari MR
    Biometals; 2019 Apr; 32(2):307-315. PubMed ID: 30874991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Comprehensive Transcriptome Analysis Identifies FXN and BDNF as Novel Targets of miRNAs in Friedreich's Ataxia Patients.
    Misiorek JO; Schreiber AM; Urbanek-Trzeciak MO; Jazurek-Ciesiołka M; Hauser LA; Lynch DR; Napierala JS; Napierala M
    Mol Neurobiol; 2020 Jun; 57(6):2639-2653. PubMed ID: 32291635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel Nrf2-Inducer Prevents Mitochondrial Defects and Oxidative Stress in Friedreich's Ataxia Models.
    Abeti R; Baccaro A; Esteras N; Giunti P
    Front Cell Neurosci; 2018; 12():188. PubMed ID: 30065630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR gamma agonist leriglitazone improves frataxin-loss impairments in cellular and animal models of Friedreich Ataxia.
    Rodríguez-Pascau L; Britti E; Calap-Quintana P; Dong YN; Vergara C; Delaspre F; Medina-Carbonero M; Tamarit J; Pallardó FV; Gonzalez-Cabo P; Ros J; Lynch DR; Martinell M; Pizcueta P
    Neurobiol Dis; 2021 Jan; 148():105162. PubMed ID: 33171227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An In Silico Analysis of Genetic Variants and Structural Modeling of the Human Frataxin Protein in Friedreich's Ataxia.
    Da Conceição LMA; Cabral LM; Pereira GRC; De Mesquita JF
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient attenuation of Friedreich's ataxia (FRDA) cardiomyopathy by modulation of iron homeostasis-human induced pluripotent stem cell (hiPSC) as a drug screening platform for FRDA.
    Lee YK; Lau YM; Ng KM; Lai WH; Ho SL; Tse HF; Siu CW; Ho PW
    Int J Cardiol; 2016 Jan; 203():964-71. PubMed ID: 26625322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neurodegeneration in Friedreich's ataxia: from defective frataxin to oxidative stress.
    Gomes CM; Santos R
    Oxid Med Cell Longev; 2013; 2013():487534. PubMed ID: 23936609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of Iron in Friedreich's Ataxia: Insights From Studies in Human Tissues and Cellular and Animal Models.
    Llorens JV; Soriano S; Calap-Quintana P; Gonzalez-Cabo P; Moltó MD
    Front Neurosci; 2019; 13():75. PubMed ID: 30833885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous Quantification of Mitochondrial Mature Frataxin and Extra-Mitochondrial Frataxin Isoform E in Friedreich's Ataxia Blood.
    Wang Q; Laboureur L; Weng L; Eskenazi NM; Hauser LA; Mesaros C; Lynch DR; Blair IA
    Front Neurosci; 2022; 16():874768. PubMed ID: 35573317
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitofusin-Dependent ER Stress Triggers Glial Dysfunction and Nervous System Degeneration in a
    Edenharter O; Schneuwly S; Navarro JA
    Front Mol Neurosci; 2018; 11():38. PubMed ID: 29563863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMTase Inhibitors as a Potential Epigenetic-Based Therapeutic Approach for Friedreich's Ataxia.
    Sherzai M; Valle A; Perry N; Kalef-Ezra E; Al-Mahdawi S; Pook M; Anjomani Virmouni S
    Front Genet; 2020; 11():584. PubMed ID: 32582297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.